๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers Clinical trials Suzhou
Clinical trial register · China

Clinical Trials in Suzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Suzhou 115 Hefei 1 Luoyang 1 Wuhan 1 Changzhou 1
Narrow the registerReset
Recruitment status
Phase
Site location
Suzhou115 Hefei1 Luoyang1 Wuhan1 Changzhou1
All 13 locations
Target enrolment
to

Trials with a site in Suzhou

115 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia
NCT05566054Acute Monocytic Leukemia, Newly Diagnosed
The First Affiliated Hospital of Soochow University
Phase 2
92
Suzhou
2022-03-01
Active, closed
New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
NCT05029141Acute Myeloid Leukemia, Refractory Acute Leukemia, Relapsed Adult AML
The First Affiliated Hospital of Soochow University
Phase 2
21
Suzhou
2021-09-01
Recruiting
Efficacy and Safety of Auto-FMT in Preventing aGVHD
NCT04745221Graft Versus Host Disease, Acute
The First Affiliated Hospital of Soochow University
Not applicable
100
Suzhou
2021-03-01
Recruiting
Relationship Between "FODMAPs" and "GVHD"
NCT04660487Graft Versus Host Disease
The First Affiliated Hospital of Soochow University
Observational
100
Suzhou
2020-12-01
Active, closed
CD22/CD19 CAR-T and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL
NCT05470777B-cell Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University
Phase 2
37
Suzhou
2020-01-19
Recruiting
Clinical Study on Anti-PD-1 Plus Lenalidomide and Azacitidine in Relapsed/Refractory Peripheral T-cell Lymphoma
NCT05182957Relapsed/Refractory Peripheral T-cell Lymphoma
The First Affiliated Hospital of Soochow University
Phase 2
31
Suzhou
2020-01-01
Recruiting
Comparation of Chidamide Plus VRD (Bortezomib, Lenalidomide, Dexamethasone) With VRD Regimen for Primary High-Risk Multiple Myeloma Patients
NCT04025450Multiple Myeloma
The First Affiliated Hospital of Soochow University
Phase 1/2
50
Suzhou
2019-07-15
Active, closed
Maintenance Therapy of Hypomethylating Agent (HMA) in Favorable Risk Acute Myeloid Leukemia (AML) Patients
NCT06379360Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
Phase 2
60
Suzhou
2019-07-01
Recruiting
Nutritional Status of Patients After Hematopoietic Stem Cell Transplantation
NCT04146870Nutrition, Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University
Observational
200
Suzhou
2018-10-01
Active, closed
Study of T Cells Targeting CD19/BCMA (CART-19/BCMA) for High Risk Multiple Myeloma Followed With Auto-HSCT
NCT03455972Safety and Efficacy
The First Affiliated Hospital of Soochow University
Phase 1/2
43
Suzhou
2018-02-20
Active, closed
CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia
NCT03984968Acute Lymphoblastic Leukemia, Adult B-Cell
The First Affiliated Hospital of Soochow University
Phase 1/2
40
Suzhou
2017-07-10
Recruiting
FMT in Gut aGVHD Treated
NCT03148743Acute-graft-versus-host Disease
The First Affiliated Hospital of Soochow University
Observational
50
Suzhou
2017-05-16
Recruiting
Study of T Cells Targeting CD138/BCMA/CD19/More Antigens (CART-138/BCMA/19/More) for Chemotherapy Refractory and Relapsed Multiple Myeloma
NCT03196414Multiple Myeloma
The First Affiliated Hospital of Soochow University
Phase 1/2
10
Suzhou
2016-09
Active, closed
CAR-T Cell Therapy Targeting to CD19 for R/R ALL
NCT03919240Acute Lymphoblastic Leukemia With Failed Remission
The First Affiliated Hospital of Soochow University
Phase 1/2
196
Suzhou
2015-12-01
By invitation
Follow-up Study of ICUS and CCUS Patients
NCT04428489Myelodysplastic Syndromes
The First Affiliated Hospital of Soochow University
Observational
300
Suzhou
2011-01-01
Rows per page Showing 101–115 of 115
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/suzhou?page=2

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 115 of those studies with a site in Suzhou that also match the filters currently applied.

How many clinical trials are recruiting in Suzhou?

81 of the 115 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 18 have not yet opened recruitment, 11 are active but closed to new participants, and 5 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.